Last reviewed · How we verify
NCT05516485
Measuring Brain Tumor Consistency Using Magnetic Resonance Elastography
NA trial testing Assessment in Brain Neoplasm. Withdrawn.
1 October 2027
Quick facts
| Lead sponsor | University of Southern California |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Start date | 1 October 2024 |
| Primary completion | 1 October 2027 |
| Estimated completion | 1 October 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Assessment
- Magnetic Resonance Elastography
Conditions studied
- Brain Neoplasm — all drugs for Brain Neoplasm →
Sponsor
University of Southern California
Who can join
18 and older, any sex, with Brain Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial tests whether a new imaging technique called magnetic resonance elastography (MRE) is useful in determining the consistency of brain tumors and whether this could be used to guide surgical planning and choice of approach (the type of surgery that is needed) for patients with brain tumors. Comparing MRE with the typical magnetic resonance imaging (MRI) scan may help researchers assess the quality, reliability, and diagnostic utility of this scan when evaluating brain tumors.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05516485
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Assessment
Trials testing the same drug.
- NCT07520981 — Functional Capacity, Subjective Dyspnea and Fatigue in Smokers · not yet recruiting
- NCT07225920 — Understanding Needs of Older Patients Prior to Starting Cancer Treatment · NA · enrolling by invitation
- NCT07249541 — Hypermobility, Foot Posture, and Scoliosis Severity · not yet recruiting
- NCT07256873 — Validity and Reliability of Face-to-Face and Tele-Assessment of Core Stability and Functional Capacity · completed
- NCT07249515 — Scapula and Upper Extremity Performance in Scoliosis · recruiting
Other recruiting trials for Brain Neoplasm
Currently open trials in the same condition.
- NCT04553757 — Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma · active not recruiting
- NCT05087888 — MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation · active not recruiting
- NCT03606161 — Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumo · NA · active not recruiting
- NCT02754544 — Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors · NA · recruiting
- NCT02639325 — Tumor Related Epilepsy · recruiting
Other University of Southern California trials
Trials by the same sponsor.
- NCT07288463 — Hearing Loss and Genetic Risks for Alzheimer's Disease and Related Dementia · NA · not yet recruiting
- NCT05914233 — Non-invasive Ultrasound Retinal Stimulation for Vision Restoration · NA · not yet recruiting
- NCT06163664 — Role of ChatGPT in Vestibular Schwannoma Management · NA · withdrawn
- NCT07332312 — A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind · NA · not yet recruiting
- NCT07290478 — Encouraging Older Adults and Adults With Serious Illness to Designate a Health Care Proxy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05516485 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southern California
- Last refreshed: 4 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05516485.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing